LAMP1 and neoplasm: To investigate the effect of NKG2A expression on the anti-tumor response of IL-2-activated NK cells against HLA-class I negative target cells, we performed a flow cytometry-based degranulation (CD107a) assay by co-culturing NK cells and HLA-class I negative K562 cells followed by staining for KIRs and NKG2A to enable NK subset analysis.